aluates Reports

$ 0.0

Automative

Global Myasthenia Gravis Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-3D13735

Global Myasthenia Gravis Market Research Report 2023

BUY CHAPTERS

Global Myasthenia Gravis Market Research Report 2025

Code: QYRE-Auto-3D13735

Report

September 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Takeda

Avadel Pharmaceuticals

Baxter International

Novartis

Bausch Health

Grifols S A

Roche

CSL Limited

Astrazeneca plc

Octapharma AG

Astellas Pharma

Zydus Lifesciences

Kedrion S p A

Myasthenia Gravis Market Size

The global market for Myasthenia Gravis was valued at US$ 1426 million in the year 2024 and is projected to reach a revised size of US$ 2188 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Myasthenia Gravis Market

Myasthenia gravis is a chronic autoimmune, neuromuscular disease that causes weakness in the skeletal muscles (the muscles that connect to your bones and contract to allow body movement in the arms and legs, and allow for breathing).

North American market for Myasthenia Gravis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Myasthenia Gravis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Myasthenia Gravis in Hospital Pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Myasthenia Gravis include Takeda, Roche, CSL Limited, Baxter International, Novartis, Bausch Health, Grifols, AstraZeneca, Avadel Pharmaceuticals, Octapharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Myasthenia Gravis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myasthenia Gravis.

The Myasthenia Gravis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Myasthenia Gravis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Myasthenia Gravis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Myasthenia Gravis Market Report

Report Metric	Details
Report Name	Myasthenia Gravis Market
Accounted market size in year	US$ 1426 million
Forecasted market size in 2031	US$ 2188 million
CAGR	6.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Monoclonal Antibodies Intravenous Immunoglobulin Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, Roche, CSL Limited, Baxter International, Novartis, Bausch Health, Grifols, AstraZeneca, Avadel Pharmaceuticals, Octapharma, Astellas Pharma, Zydus Lifesciences, Kedrion S.p.A.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Myasthenia Gravis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Myasthenia Gravis Market growing?

Ans: The Myasthenia Gravis Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Myasthenia Gravis Market size in 2031?

Ans: The Myasthenia Gravis Market size in 2031 will be US$ 2188 million.

Who are the main players in the Myasthenia Gravis Market report?

Ans: The main players in the Myasthenia Gravis Market are Takeda, Roche, CSL Limited, Baxter International, Novartis, Bausch Health, Grifols, AstraZeneca, Avadel Pharmaceuticals, Octapharma, Astellas Pharma, Zydus Lifesciences, Kedrion S.p.A.

What are the Application segmentation covered in the Myasthenia Gravis Market report?

Ans: The Applications covered in the Myasthenia Gravis Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Myasthenia Gravis Market report?

Ans: The Types covered in the Myasthenia Gravis Market report are Monoclonal Antibodies, Intravenous Immunoglobulin, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Myasthenia Gravis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Monoclonal Antibodies

1.2.3 Intravenous Immunoglobulin

1.2.4 Others

1.3 Market by Application

1.3.1 Global Myasthenia Gravis Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Myasthenia Gravis Market Perspective (2020-2031)

2.2 Global Myasthenia Gravis Growth Trends by Region

2.2.1 Global Myasthenia Gravis Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Myasthenia Gravis Historic Market Size by Region (2020-2025)

2.2.3 Myasthenia Gravis Forecasted Market Size by Region (2026-2031)

2.3 Myasthenia Gravis Market Dynamics

2.3.1 Myasthenia Gravis Industry Trends

2.3.2 Myasthenia Gravis Market Drivers

2.3.3 Myasthenia Gravis Market Challenges

2.3.4 Myasthenia Gravis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Myasthenia Gravis Players by Revenue

3.1.1 Global Top Myasthenia Gravis Players by Revenue (2020-2025)

3.1.2 Global Myasthenia Gravis Revenue Market Share by Players (2020-2025)

3.2 Global Myasthenia Gravis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Myasthenia Gravis Revenue

3.4 Global Myasthenia Gravis Market Concentration Ratio

3.4.1 Global Myasthenia Gravis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Revenue in 2024

3.5 Global Key Players of Myasthenia Gravis Head office and Area Served

3.6 Global Key Players of Myasthenia Gravis, Product and Application

3.7 Global Key Players of Myasthenia Gravis, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Myasthenia Gravis Breakdown Data by Type

4.1 Global Myasthenia Gravis Historic Market Size by Type (2020-2025)

4.2 Global Myasthenia Gravis Forecasted Market Size by Type (2026-2031)

5 Myasthenia Gravis Breakdown Data by Application

5.1 Global Myasthenia Gravis Historic Market Size by Application (2020-2025)

5.2 Global Myasthenia Gravis Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Myasthenia Gravis Market Size (2020-2031)

6.2 North America Myasthenia Gravis Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Myasthenia Gravis Market Size by Country (2020-2025)

6.4 North America Myasthenia Gravis Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Myasthenia Gravis Market Size (2020-2031)

7.2 Europe Myasthenia Gravis Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Myasthenia Gravis Market Size by Country (2020-2025)

7.4 Europe Myasthenia Gravis Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Myasthenia Gravis Market Size (2020-2031)

8.2 Asia-Pacific Myasthenia Gravis Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Myasthenia Gravis Market Size by Region (2020-2025)

8.4 Asia-Pacific Myasthenia Gravis Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Myasthenia Gravis Market Size (2020-2031)

9.2 Latin America Myasthenia Gravis Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Myasthenia Gravis Market Size by Country (2020-2025)

9.4 Latin America Myasthenia Gravis Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Myasthenia Gravis Market Size (2020-2031)

10.2 Middle East & Africa Myasthenia Gravis Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Myasthenia Gravis Market Size by Country (2020-2025)

10.4 Middle East & Africa Myasthenia Gravis Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takeda

11.1.1 Takeda Company Details

11.1.2 Takeda Business Overview

11.1.3 Takeda Myasthenia Gravis Introduction

11.1.4 Takeda Revenue in Myasthenia Gravis Business (2020-2025)

11.1.5 Takeda Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Myasthenia Gravis Introduction

11.2.4 Roche Revenue in Myasthenia Gravis Business (2020-2025)

11.2.5 Roche Recent Development

11.3 CSL Limited

11.3.1 CSL Limited Company Details

11.3.2 CSL Limited Business Overview

11.3.3 CSL Limited Myasthenia Gravis Introduction

11.3.4 CSL Limited Revenue in Myasthenia Gravis Business (2020-2025)

11.3.5 CSL Limited Recent Development

11.4 Baxter International

11.4.1 Baxter International Company Details

11.4.2 Baxter International Business Overview

11.4.3 Baxter International Myasthenia Gravis Introduction

11.4.4 Baxter International Revenue in Myasthenia Gravis Business (2020-2025)

11.4.5 Baxter International Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Myasthenia Gravis Introduction

11.5.4 Novartis Revenue in Myasthenia Gravis Business (2020-2025)

11.5.5 Novartis Recent Development

11.6 Bausch Health

11.6.1 Bausch Health Company Details

11.6.2 Bausch Health Business Overview

11.6.3 Bausch Health Myasthenia Gravis Introduction

11.6.4 Bausch Health Revenue in Myasthenia Gravis Business (2020-2025)

11.6.5 Bausch Health Recent Development

11.7 Grifols

11.7.1 Grifols Company Details

11.7.2 Grifols Business Overview

11.7.3 Grifols Myasthenia Gravis Introduction

11.7.4 Grifols Revenue in Myasthenia Gravis Business (2020-2025)

11.7.5 Grifols Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Myasthenia Gravis Introduction

11.8.4 AstraZeneca Revenue in Myasthenia Gravis Business (2020-2025)

11.8.5 AstraZeneca Recent Development

11.9 Avadel Pharmaceuticals

11.9.1 Avadel Pharmaceuticals Company Details

11.9.2 Avadel Pharmaceuticals Business Overview

11.9.3 Avadel Pharmaceuticals Myasthenia Gravis Introduction

11.9.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2020-2025)

11.9.5 Avadel Pharmaceuticals Recent Development

11.10 Octapharma

11.10.1 Octapharma Company Details

11.10.2 Octapharma Business Overview

11.10.3 Octapharma Myasthenia Gravis Introduction

11.10.4 Octapharma Revenue in Myasthenia Gravis Business (2020-2025)

11.10.5 Octapharma Recent Development

11.11 Astellas Pharma

11.11.1 Astellas Pharma Company Details

11.11.2 Astellas Pharma Business Overview

11.11.3 Astellas Pharma Myasthenia Gravis Introduction

11.11.4 Astellas Pharma Revenue in Myasthenia Gravis Business (2020-2025)

11.11.5 Astellas Pharma Recent Development

11.12 Zydus Lifesciences

11.12.1 Zydus Lifesciences Company Details

11.12.2 Zydus Lifesciences Business Overview

11.12.3 Zydus Lifesciences Myasthenia Gravis Introduction

11.12.4 Zydus Lifesciences Revenue in Myasthenia Gravis Business (2020-2025)

11.12.5 Zydus Lifesciences Recent Development

11.13 Kedrion S.p.A.

11.13.1 Kedrion S.p.A. Company Details

11.13.2 Kedrion S.p.A. Business Overview

11.13.3 Kedrion S.p.A. Myasthenia Gravis Introduction

11.13.4 Kedrion S.p.A. Revenue in Myasthenia Gravis Business (2020-2025)

11.13.5 Kedrion S.p.A. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Takeda

Avadel Pharmaceuticals

Baxter International

Novartis

Bausch Health

Grifols S A

Roche

CSL Limited

Astrazeneca plc

Octapharma AG

Astellas Pharma

Zydus Lifesciences

Kedrion S p A

List of Tables

Table 1. Global Myasthenia Gravis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Intravenous Immunoglobulin

Table 4. Key Players of Others

Table 5. Global Myasthenia Gravis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Myasthenia Gravis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Myasthenia Gravis Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Myasthenia Gravis Market Share by Region (2020-2025)

Table 9. Global Myasthenia Gravis Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Myasthenia Gravis Market Share by Region (2026-2031)

Table 11. Myasthenia Gravis Market Trends

Table 12. Myasthenia Gravis Market Drivers

Table 13. Myasthenia Gravis Market Challenges

Table 14. Myasthenia Gravis Market Restraints

Table 15. Global Myasthenia Gravis Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Myasthenia Gravis Market Share by Players (2020-2025)

Table 17. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2024)

Table 18. Ranking of Global Top Myasthenia Gravis Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Myasthenia Gravis Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Myasthenia Gravis, Headquarters and Area Served

Table 21. Global Key Players of Myasthenia Gravis, Product and Application

Table 22. Global Key Players of Myasthenia Gravis, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Myasthenia Gravis Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Myasthenia Gravis Revenue Market Share by Type (2020-2025)

Table 26. Global Myasthenia Gravis Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Myasthenia Gravis Revenue Market Share by Type (2026-2031)

Table 28. Global Myasthenia Gravis Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Myasthenia Gravis Revenue Market Share by Application (2020-2025)

Table 30. Global Myasthenia Gravis Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Myasthenia Gravis Revenue Market Share by Application (2026-2031)

Table 32. North America Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Myasthenia Gravis Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Myasthenia Gravis Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Myasthenia Gravis Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Myasthenia Gravis Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Myasthenia Gravis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Myasthenia Gravis Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Myasthenia Gravis Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Myasthenia Gravis Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Myasthenia Gravis Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Myasthenia Gravis Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Myasthenia Gravis Market Size by Country (2026-2031) & (US$ Million)

Table 47. Takeda Company Details

Table 48. Takeda Business Overview

Table 49. Takeda Myasthenia Gravis Product

Table 50. Takeda Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 51. Takeda Recent Development

Table 52. Roche Company Details

Table 53. Roche Business Overview

Table 54. Roche Myasthenia Gravis Product

Table 55. Roche Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 56. Roche Recent Development

Table 57. CSL Limited Company Details

Table 58. CSL Limited Business Overview

Table 59. CSL Limited Myasthenia Gravis Product

Table 60. CSL Limited Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 61. CSL Limited Recent Development

Table 62. Baxter International Company Details

Table 63. Baxter International Business Overview

Table 64. Baxter International Myasthenia Gravis Product

Table 65. Baxter International Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 66. Baxter International Recent Development

Table 67. Novartis Company Details

Table 68. Novartis Business Overview

Table 69. Novartis Myasthenia Gravis Product

Table 70. Novartis Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 71. Novartis Recent Development

Table 72. Bausch Health Company Details

Table 73. Bausch Health Business Overview

Table 74. Bausch Health Myasthenia Gravis Product

Table 75. Bausch Health Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 76. Bausch Health Recent Development

Table 77. Grifols Company Details

Table 78. Grifols Business Overview

Table 79. Grifols Myasthenia Gravis Product

Table 80. Grifols Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 81. Grifols Recent Development

Table 82. AstraZeneca Company Details

Table 83. AstraZeneca Business Overview

Table 84. AstraZeneca Myasthenia Gravis Product

Table 85. AstraZeneca Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 86. AstraZeneca Recent Development

Table 87. Avadel Pharmaceuticals Company Details

Table 88. Avadel Pharmaceuticals Business Overview

Table 89. Avadel Pharmaceuticals Myasthenia Gravis Product

Table 90. Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 91. Avadel Pharmaceuticals Recent Development

Table 92. Octapharma Company Details

Table 93. Octapharma Business Overview

Table 94. Octapharma Myasthenia Gravis Product

Table 95. Octapharma Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 96. Octapharma Recent Development

Table 97. Astellas Pharma Company Details

Table 98. Astellas Pharma Business Overview

Table 99. Astellas Pharma Myasthenia Gravis Product

Table 100. Astellas Pharma Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 101. Astellas Pharma Recent Development

Table 102. Zydus Lifesciences Company Details

Table 103. Zydus Lifesciences Business Overview

Table 104. Zydus Lifesciences Myasthenia Gravis Product

Table 105. Zydus Lifesciences Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 106. Zydus Lifesciences Recent Development

Table 107. Kedrion S.p.A. Company Details

Table 108. Kedrion S.p.A. Business Overview

Table 109. Kedrion S.p.A. Myasthenia Gravis Product

Table 110. Kedrion S.p.A. Revenue in Myasthenia Gravis Business (2020-2025) & (US$ Million)

Table 111. Kedrion S.p.A. Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Myasthenia Gravis Picture

Figure 2. Global Myasthenia Gravis Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Myasthenia Gravis Market Share by Type: 2024 VS 2031

Figure 4. Monoclonal Antibodies Features

Figure 5. Intravenous Immunoglobulin Features

Figure 6. Others Features

Figure 7. Global Myasthenia Gravis Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Myasthenia Gravis Market Share by Application: 2024 VS 2031

Figure 9. Hospital Pharmacies Case Studies

Figure 10. Retail Pharmacies Case Studies

Figure 11. Online Pharmacies Case Studies

Figure 12. Myasthenia Gravis Report Years Considered

Figure 13. Global Myasthenia Gravis Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Myasthenia Gravis Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Myasthenia Gravis Market Share by Region: 2024 VS 2031

Figure 16. Global Myasthenia Gravis Market Share by Players in 2024

Figure 17. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Myasthenia Gravis Revenue in 2024

Figure 19. North America Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Myasthenia Gravis Market Share by Country (2020-2031)

Figure 21. United States Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Myasthenia Gravis Market Share by Country (2020-2031)

Figure 25. Germany Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Myasthenia Gravis Market Share by Region (2020-2031)

Figure 33. China Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Myasthenia Gravis Market Share by Country (2020-2031)

Figure 41. Mexico Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Myasthenia Gravis Market Share by Country (2020-2031)

Figure 45. Turkey Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Myasthenia Gravis Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Takeda Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 49. Roche Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 50. CSL Limited Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 51. Baxter International Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 52. Novartis Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 53. Bausch Health Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 54. Grifols Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 55. AstraZeneca Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 56. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 57. Octapharma Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 58. Astellas Pharma Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 59. Zydus Lifesciences Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 60. Kedrion S.p.A. Revenue Growth Rate in Myasthenia Gravis Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Sarcopenia Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sarcopenia Treatments Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Lambert Eaton Myasthenic Syndrome Treatment Market Insights Forecast to 2030

Autoimmune Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Spinal Muscular Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Myotonic Dystrophy Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Muscarinic Acetylcholine Receptor Market Research Report 2025

Global Myasthenia Gravis Drugs Market Research Report 2025

Neuromuscular Blocking Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Myotonic Dystrophy Treatment Market Research Report 2025

Sarcopenia Supplement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Myasthenia Gravis MG Treatment Market Research Report 2024

Autoimmune Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Spinal Muscular Atrophy SMA Treatment Market Research Report 2024

Global Myasthenia Gravis Diagnostic Reagents and Equipment Market Research Report 2025

Dermatomyositis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fc Fusion Protein for Autoimmune Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Myasthenia Gravis Treatment Market Research Report 2025

Treatment for Syndromes of Progressive Ataxia and Weakness Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions